Phytomedicines in Pharmacotherapy of LUTS/BPH – What Do Patients Think?
We found that phytomedicines were the second most common drug class taken by LUTS patients at our hospital. Reasons may be easy availability as over the counter medication and a superior safety profile with less bothersome side effects than commonly prescribed drug classes. Taken together, phytomedicines may be able to bridge an important gap in LUTS pharmacotherapy to provide sufficient treatment adherence where prescription drug classes fail, and ultimately, adequate improvement of symptoms. However, patients need to be counseled on potentially limited efficacy.
Authors
- Alexander Tamalunas (ORCID: https://orcid.org/0000-0002-4659-2262)
- Martin Hennenberg (ORCID: https://orcid.org/0000-0003-1305-6727)
- Giuseppe Magistro (ORCID: https://orcid.org/0000-0001-9872-7766)
- Christian Georg Stief (ORCID: https://orcid.org/0000-0003-3291-9460)
- Alexander Büchner (ORCID: https://orcid.org/0000-0001-7895-7070)
- Philipp Lenau
- Leo Stadelmeier
- Thomas Kolben
- Richard Paktiaval
Institutions
- LMU Klinikum (DE)
- Asklepios (DE)
- BG Klinikum Hamburg (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Patient Preference and Adherence
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/ppa.s484632
- Citations
- 2
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 1.07